Eduardo has more than 20 years’ experience in the pharmaceutical industry. His prior professional career includes several senior management positions at Sanofi-Aventis, including the Vice-Presidency for Latin America, where he was in charge of more than 2,000 employees and for generation of more than €1 billion sales. At Sanofi-Aventis he also held the positions of Marketing and Sales Manager for Europe and General Manager in Belgium. Eduardo also worked for 7 years at SmithKline Beecham in both national and international commercial positions. Eduardo holds a degree in Business Administration and an MBA (INSEAD, Fontainebleau, France). Eduardo Bravo is also a member of the Cellerix Board of Directors.

Claudia has more than 20 years of experience in finance. After completing her PhD, she joined the Corporate Finance Department at Deloitte & Touche in Milan. She then moved to Apax Partners in Madrid, where she was responsible for setting up and implementation of M&A Transactions. She was subsequently Chief Financial Officer at Aquanima (Grupo Santander). Claudia holds a degree in Economics from the University of Bocconi, Italy and is a Visiting Fellow at Harvard University, USA.

At the start of his professional career, during the first four years, José Luis practiced intensive care medicine at different clinics and hospitals in Madrid. His career in the pharmaceutical industry started in 1987 and has continued to date. During his long professional experience, he has acted as Medical and Research and Development Director in companies such as Janssen, Hoechst Marion Roussel, Dupont Pharmaceutical, Bristol Myers Squibb, Schwarz Pharma, and finally UCB, where as Medical Director he undertook the task of creating a new structure of the medical department following the merger of Schwarz Pharma and UCB. José Luis holds a PhD in Medicine and Surgery from Universidad Complutense de Madrid.

María has an intensive research experience at the Spanish Scientific Research Council (CSIC) and was granted the international Julia Bodmer Award. Her international experience includes work at the Mayo Clinic (MN, USA) and the Leiden University Medical Center (The Netherlands). María specialized in clinical development and regulatory affairs in the area of advanced therapies. She has held different positions at the regulatory affairs area. María participates actively in different technical working and lobby groups of European industry in the field of advanced therapies and is currently an expert consultant in advanced therapies for the European Medicines Agency (EMEA). María holds a degree in Pharmacy from the University of Granada and a PhD in Pharmacy from the CSIC.

Claudia began her professional career in the WestLB AG investment bank (Germany), where she held a number of positions in her 5-year stay, the most recent being in the M&A Department, where she directed projects in several industries, including the pharmaceutical industry and biotechnology. Claudia has degrees in International Business Studies from the Universidad Pontificia Comillas (ICADE) and the FDH Reutlingen (Germany), and an MBA from the Instituto de Empresa, Madrid.

Aitor initially worked at the R&D Department of Cellerix in biochemical and functional characterization of stem cells. He is currently the head of the Pharmaceutical Development Department, entrusted with the task of improving both the manufacturing and quality processes for company products by incorporating new techniques which allow for developing new manufacturing controls and product specifications.
Aitor holds a degree in Chemistry (in the specialty of Biochemistry) and a master’s degree in Molecular Biology (Universidad Autónoma de Madrid), and is currently working on his doctoral dissertation (Universidad Autónoma de Madrid) Aitor speaks English and Spanish.

Lydia has more than 12 years’ experience in the clinical operations area in different pharmaceutical companies. She previously worked in the Clinical Investigation area at Amersham Health laboratories during seven years. Lydia then worked at GE Healthcare, where she held different positions. After that, and during three years, Lydia was a Clinical Research Manager in the CRO_Trial Form Support acting as Project Manager for various projects. Before joining Cellerix, she worked at Casen-Fleet as Medical Project Manager, EMEAI. Lydia holds a Pharmaceutical Degree from the Universidad de Alcalá de Henares (Spain) and a MBA in Pharmaceutical and Para-pharmaceutical Industry from the Centro de Estudios Superiores de la Industria Farmacéutica (CESIF).

Gemma has 5 years of experience working in research in the field of stem cells and in specialist laboratories. Since joining Cellerix, she and her team have reached some key milestones, such as obtaining accreditation for Cellerix as a pharmaceutical company by the AEMPS (Spanish Medicines Agency) and the management of the clinical trials undertaken by the company. Gemma is a Biology graduate from the Universidad Complutense in Madrid and has a PhD in Biology awarded by the University of Alcalá de Henares, Spain.

Virginia has several years of experience working in financial departments. Before joining Cellerix Virginia worked at Decathlon where she held a number of positions, with a diverse range of responsibilities. These included the auditing and management of large retail accounts, as well as having responsibility for further education within the department. At Cellerix, she has contributed to building a solid financial department, during a very strategic stage in the company´s development. Virginia has a degree in Business Management from the University of Oviedo and a Master´s degree in Economic and Financial Management.

Eleuterio has 18 years of scientific experience in the fields of virology, innate immunity, inflammation, embryonic development, and stem cells. Before entering Cellerix, Eleuterio developed a scientific career at some of the most important research centers in Spain (Severo Ochoa Molecular Biology Center, National Biotechnology Center, and National Cardiovascular Research Center) and the United States (The Salk Institute and The Scripps Research Institute), where he worked for five years. He joined Cellerix four years ago, and has since contributed to strengthen the basic and preclinical research programs related to use of allogeneic stem cells derived from adipose tissue. Eleuterio holds a degree in Biology (1992) and a PhD in Biochemistry and Molecular Biology (1997) from Universidad Autónoma de Madrid.

Olga has devoted 10 years to research in the field of cell immunology. Her scientific career includes publications, congresses, and teaching. In addition, she learned many methodologies related to function of the adaptive immune system during research at the Department of Immunology of Reina Sofía University Hospital in Cordoba, and in her stays at the Guy’s, King’s and St Thomas’ School of Medicine (London) and the Alexandrovska University Hospital in Sofia, Bulgaria. Olga entered the field of cell therapy at the Klinik und Poliklinik für Onkologie, UniversitätsSpital (Zurich), working in tumor immunology (adoptive immunotherapy). She has participated as a scientist in national and European research networks and programs. Olga holds a degree and a PhD degree from Universidad de Córdoba and speaks English and Spanish.

Before joining Cellerix, Debjani worked for eight years as Manager of Intellectual Property for the biotechnology company Epigenomics. During that period she managed a significant patent portfolio, developed corporate Intellectual Property strategy, assisted in license agreements and supported the company during its IPO and over several financing rounds. Debjani has degrees in Genetics and Management of Intellectual Property from the University of London, and qualified as a European Patent Attorney in 2007.